Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$1.4 million.

  • Ekso Bionics Holdings' Profit After Tax rose 3141.89% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.4 million, marking a year-over-year increase of 626.18%. This contributed to the annual value of -$11.3 million for FY2024, which is 2545.07% up from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Profit After Tax stood at -$1.4 million, which was up 3141.89% from -$2.7 million recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Profit After Tax peaked at -$1.3 million during Q2 2021, and registered a low of -$4.6 million during Q1 2022.
  • Over the past 5 years, Ekso Bionics Holdings' median Profit After Tax value was -$3.2 million (recorded in 2022), while the average stood at -$3.1 million.
  • The largest annual percentage gain for Ekso Bionics Holdings' Profit After Tax in the last 5 years was 8918.16% (2021), contrasted with its biggest fall of 17985.32% (2021).
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Profit After Tax stood at -$2.9 million in 2021, then fell by 11.0% to -$3.2 million in 2022, then decreased by 1.13% to -$3.2 million in 2023, then fell by 6.19% to -$3.4 million in 2024, then soared by 58.37% to -$1.4 million in 2025.
  • Its Profit After Tax was -$1.4 million in Q3 2025, compared to -$2.7 million in Q2 2025 and -$2.9 million in Q1 2025.